Blotz A, Michel L, Moysan A, Blümel J, Dubertret L, Ahr H J, Vohr H W
Institute of Toxicology, Bayer AG, Wuppertal, Germany.
J Photochem Photobiol B. 2000 Oct;58(1):46-53. doi: 10.1016/s1011-1344(00)00097-x.
Currently available test models for the differentiation of photoallergic and photoirritant reactions are extremely time consuming and the protocols are very heterogeneous. In vitro tests are of proven value in predicting irritant or toxic effects, but these tests fail to predict chemical-induced allergic side effects. We developed test systems for this endpoint which is not easily detected by existing assays. In a previous publication we were able to discriminate between a contact sensitizer and a skin irritant with a combination of primary ear swelling analysis and cell counting of the ear-draining lymph nodes [Toxicol. Appl. Pharm. 153 (1998) 83; Arch. Toxicol. 73 (2000) 501]. This combination of tests was called the Integrated Model for the Differentiation of chemical-induced allergic and irritant Skin reactions (IMDS). In addition, it had been shown before that inclusion of UV irradiation in the local lymph node assay enables discrimination of photoallergic from photoirritant reactions after dermal application [Photodermatol. Photoimmunol. Photomed. 10 (1994) 57]. Because of the fact that fluoroquinolones are known to induce photoreactions after oral but not dermal treatment, the aim of the present study was to apply the IMDS for the fast and reliable differentiation of photoreactions due to fluoroquinolones after oral treatment. Enoxacin, lomefloxacin, ofloxacin, sparfloxacin and BAY y 3118 were tested in this system. We found a good correlation between the results of UV light-irradiated IMDS and a guinea pig model with the quinolones as far as photoirritancy was concerned. This holds true also for the photoallergic standard olaquindox and the photoirritant standard 8-methoxypsoralen. However, in contrast to the guinea pig assays the IMDS is fast and extremely predictive for the risk of both photosensitization and photoirritancy depending on the route of exposure. Thus, the UV light-irradiated IMDS turned out to be a good tool for the preclinical risk assessment procedure in terms of discriminating photoreactions. In addition, flow cytometric analyses were used to underline the fact that antigen-independent activation occurred after the induction of photoirritant reactions.
目前用于区分光变应性和光刺激性反应的测试模型极其耗时,且方案非常不一致。体外试验在预测刺激或毒性作用方面已被证明具有价值,但这些试验无法预测化学诱导的过敏副作用。我们针对这一现有检测方法不易检测到的终点开发了测试系统。在之前的一篇出版物中,我们能够通过结合原发性耳部肿胀分析和耳部引流淋巴结细胞计数来区分接触性致敏剂和皮肤刺激物[《毒理学与应用药理学》153(1998)83;《毒理学档案》73(2000)501]。这种测试组合被称为化学诱导的过敏性和刺激性皮肤反应鉴别综合模型(IMDS)。此外,之前已经表明,在局部淋巴结试验中加入紫外线照射能够在皮肤应用后区分光变应性和光刺激性反应[《光皮肤病学、光免疫学与光医学》10(1994)57]。由于已知氟喹诺酮类药物在口服而非皮肤治疗后会引发光反应,本研究的目的是应用IMDS快速、可靠地区分口服治疗后氟喹诺酮类药物引起的光反应。在该系统中对依诺沙星、洛美沙星、氧氟沙星、司帕沙星和BAY y 3118进行了测试。就光刺激性而言,我们发现紫外线照射的IMDS结果与喹诺酮类药物的豚鼠模型之间有良好的相关性。这对于光变应性标准品喹乙醇和光刺激性标准品8-甲氧基补骨脂素也成立。然而,与豚鼠试验不同的是,IMDS快速且能根据暴露途径极其准确地预测光致敏和光刺激的风险。因此,紫外线照射的IMDS被证明是在区分光反应方面进行临床前风险评估程序的良好工具。此外,流式细胞术分析用于强调光刺激性反应诱导后发生抗原非依赖性激活这一事实。